Many people are familiar with histamine, a biological molecule that serves as a key driver of allergic reactions and other ...
Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...
Bariatric surgery and GLP-1 drugs are associated with reductions in fat mass and a shift in body composition toward a higher ...
Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to ...
A research team of the University Medical Center Mainz has succeeded in observing for the first time how G protein-coupled ...
Researchers uncover a hidden nanoscale mechanism critical for Met receptor activation, providing a new blueprint for targeted ...
The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...
Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.
GLP-1 receptor agonist (RA) prescribing increased from 0.2 to 6.4 per 1000 deliveries predelivery and from 0.3 to 14.6 per 1000 deliveries postdelivery between 2019 and 2024. Among recipients in 2024, ...
Among adolescents with asthma and overweight or obesity, the relative risk for acute asthma exacerbations was significantly reduced with GLP-1 receptor agonist use vs. nonpharmacological weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback